Sdi Share Discussion Threads

[buywell3] 20/1/2019 01:36

Here is the situation in France NOTHING like it has been done to my knowledge in the UK NHS or otherwise (private practice)

Published online 2018 Apr 25.

Observance of Sterilization Protocol Guideline Procedures of Critical Instruments for Preventing Iatrogenic Transmission of Creutzfeldt-Jakob Disease in Dental Practice in France, 2017



''The aim of this study was to evaluate, in accordance with the WHO guidelines, the observance of sterilization procedures for preventing iatrogenic transmission of Creutzfeldt-Jakob disease, including of reusable instruments in actual conditions of care in French dental practices.''

''Despite the emergence of recent studies, evidence remains limited on the quality of implementation of sterilization procedures in dental practices [26].

This is one of the few recent surveys conducted on this topic in French dental practices and specifically focused on sterilization processes of instruments.

As a rule, the overall adherence level to procedures was unsatisfactory for most of the 179 dental practices.

The percentages of practices correctly performing over 80% of the procedures ranged from 6.6% to 45.7% in the four groups.''



Conclusions

In conclusion, the practitioner is obligated to provide results regarding sterilization.

The practitioner, and no one else, is responsible for health safety and for infectious risks in his dental office.

He is responsible for permanently establishing proof of his actions.

These standard recommendations—simple, basic—may reduce the risk of CJD infections during care, but they must be impeccable in their implementation.

Following the discovery of the tasks not being carried out according to the guidelines in force, it is urgent to anticipate and propose alternative measures, compulsory or not, for the near future.




buywell says ... well done you frogs ... the above conclusion means that cleaned instruments need TESTING for protein residue ie 'obligated to provide results regarding sterilization.'

However the general results from the survey IMO does NOT fill one if french with any bonne confiance ... more regulation and compliance visits/audits needed.

dyor

[buywell3] 20/1/2019 00:57

IDH and My Dentist
Are owned by the Carlyle Group and it has previously been rumored as being readied for a LSE listing at around 1 Billion pounds

It has had a lot of money spent on getting it ready

Investment rationale

The UK NHS dental market was worth approximately £2.5 billion and demonstrated stable annual growth rates of 3-5%, but was highly fragmented, with only 5% of the 11,000 practices owned by corporates. ADP, as one of the only sizable players, was identified as an ideal platform with which to drive the consolidation of the market.

Value creation

M&A: At the end of 2010 Palamon partnered with The Carlyle Group to acquire competitor IDH.

In 2011 ADP and IDH were merged to form the largest dental corporate in the UK.

Diversification: Built leading market position in supply of consumables and equipment repair to UK dental practices through the acquisitions of dental buying group (2013) and Dental Directory (2014).

Strengthened management team: new CFO and new COO and appointed a new non-executive Chairman.

Completed £400m HYB issue in 2014 enabling the Company to refinance all the senior debt facilities and provide capacity for acquisitions.

Repositioned the practice network to the {my}dentist brand in 2015.

Completed a £515m refinancing in July 2016.

Today

{my}dentist is by far the largest dental corporate in the UK, with over 650 practices nationwide and serving more than 8 million patients per year.




IMO I imagine being able to say that it was the only company put patient safety first by putting into place the BEST cleaning/testing processes possible to ensure their dental instruments always complied with the latest HTM 01-01 Guidelines and thus patient safety; through clinical effectiveness; and the optimum patient experience was achieved by the use of ProReveal and Alphasonics Medstar Ultra Sonic washers.

Which both comply with HTM 01-01(2016) ,a much clearer and recent HTM Document than HTM 01-05 (2013) regarding the residual protein left on the surfaces of cleaned/washed/sterilized dental instruments : would help because :-

HTM 01-01 updated 2016 guidelines regarding

Introduction

This HTM supersedes the Choice Framework for local Policy and Procedures (CFPP) series,which was a pilot initiative by the Department of Health.

The CFPP series of documents are reverting to the Health Technical Memorandum title format.

This will realign them with HTM 00 – ‘Policies and principles of healthcare engineering’ and

‘HTM 01-05: Decontamination in primary care dental practices’

and the naming convention used for other healthcare estates and facilities related technical guidance documents within England.

It will also help to address the recommendation to align decontamination guidance across the four nations

HTM 01-01 forms a suite of evidence-based policy and guidance documents on the
management and decontamination of reusable medical devices.

Purpose

The purpose of this HTM is to help health organisations to develop policies regarding the management, use and decontamination of reusable medical devices at controlled costs using risk control, which will enable them to comply with

Regulations 12(2)(h) and 15 of the Health and Social Care Act 2008 (Regulated
Activities) Regulations 2014 .

This HTM is designed to reflect the need to continuously improve outcomes in terms of:
• patient safety;
• clinical effectiveness; and
• patient experience.



Note

This guidance remains a work in progress which will be updated as additional evidence becomes available; each iteration of the guidance is designed to help to
incrementally reduce the risk of cross-infection.


The last bit is where I see more updates as more data regarding prion diseases is published.

Prions in dentistry: A need to be concerned and known



CONCLUSION

Recently, there has been an increase in scientic and public awareness about prion disease.

The precise nature and structure of prion and the risk of transmission of prion disease through dental treatment points to the importance of maintaining optimal standards of infection control and decontamination for infectious agents, including prions.

In addition, the dental professionals should have up-to-date knowledge about transmission, diagnosis, infection control and decontamination procedures regarding prion diseases



patient safety is paramount
dyor

[buywell3] 19/1/2019 23:55

Some big names mentioned here re consolidation of Dental Practices



Bupa
Jacobs
Partick
Gensmile
Smile Clinic Ltd
Portman
Rodericks
CBPE
Avsan
Metro Dental
Dentex
Michael & Margaret Naylor
Genesis Dental Care

Integrated Dental Holdings IDH

IDH has around 550 dental practices and 10 million patients across Britain, primarily as part of the UK’s publicly funded National Health Service (NHS).

Lots more Dentists contacts via people involved with IDH



Also the My Dentist chain

[buywell3] 19/1/2019 20:27

....... The UK Dental Market it's BIG ... is SDI missing a trick ? .......


There is a growing number of larger dental practices in the UK ... I would hazard at a guess that not one of them use ProReveal to test for protein residue on their instruments after they have been cleaned /sterilized ... protein residue that may contain prions as more than 1 in every 2000 people are CJD carriers following the BSE outbreak ( CJD and BSE are both prion diseases)

The statistic presents the total number of employed and self-employed dental practitioners in the United Kingdom (UK) from 2010 to 2018. In 2018, there were:

35,000 Dental Practitioners in employment in the United Kingdom in 2018 DOWN from 51,000 in 2014. ie BIGGER Dental practices are becoming the norm.



NHS Dental Statistics for England - 2016-17 - NHS Digital



Aug 31, 2017 - There were 39.9 million Courses of Treatment (CoT) delivered in 2016-17, 241,989 (0.6 per cent) more than the number of CoT delivered in 2015-16. In the 24 month period ending 30th June 2017, 22.2 million adult patients were seen by an NHS dentist, representing 51.4 per cent of the adult population.


''We consider the environment of the decontamination room or area when we review if the practice is safe. This relates to regulation 15 (premises and equipment) and regulation 12 (safe care and treatment).

Many dental practices now have a separate decontamination room or rooms to carry out the cleaning, inspection, sterilisation and storage of dental instruments and equipment. However, due to the constraints of the building such as lack of space or listed building regulations, this may not be possible. In these situations, reprocessing dental instruments will need to take place in the dental treatment room unless other arrangements are made such as using an external central decontamination facility.

Professional guidelines: HTM 01-05: Decontamination in primary care dental practices''





HTM 01-01 is mentioned ..... also this is regarding prions ... in the form of a cop-out

Prion decontamination

1.15 Recent research has indicated that a low level of prion contamination may theoretically be present
on some instruments following contact with dental tissues. This applies if these instruments have previously been used in the care of a prion disease carrier who may exhibit no symptoms and may
indeed not go on to develop the disease.

For those tissues where evidence suggests this risk is most pronounced, the Chief Dental Officer for England has published requirements for endodontic files and reamers (see paragraph 2.18). Other
instrument or device types for which a reliable cleaning regime is not available should also be
considered for replacement by single-use types or by the single use of reprocessible instruments.

Information regarding risk in this important area is contained in ‘Potential vCJD transmission risks via
dentistry: an interim review’ (December 2007).

Note
Where patients indicate that they are in a high-risk group, guidance provided by the Advisory Committee
on Dangerous Pathogens – Transmissible Spongiform Encephalopathy Working Group (ACDP-TSE WG)
should be followed (

The guidance suggests that special precautions beyond full instrument decontamination will not be necessary.

1.16

For all other instruments used in dentistry, the risk of prion transmission will be usefully reduced by
compliance with the decontamination procedures described in this Health Technical Memorandum.

This statement is based on various studies (conducted on behalf of DH) that examined the effect of steam sterilization on prion infectivity.

These studies showed that the steam sterilization methods described in this guidance provide a useful
level of deactivation of prion infectivity. While this would not be significant in high-risk tissue surgery,
the effect is large enough to be of significance in dentistry (excluding, that is, endodontic procedures
as mentioned in paragraph 1.15).

In addition,there is a risk of prion transmission through proteincontamination of instruments, hence the measures outlined in this guidance to improve washing and disinfection of dental instruments.

1.17

Currently there is no recognised process that can fully deactivate prion protein in the sense of
removing any foreseeable level of contamination.

In this Health Technical Memorandum, the cleaning process and its ability to remove protein in tandem
with a validated steam sterilization procedure is emphasised, as this is known to at least reduce the risk of prion transmission through dental instruments.

WHAT A LOAD OF WAFFLE THE ABOVE IS

NO testing accepted level is mentioned as in HTM 01-01 for residual protein update in 2016



Although Ultra Sonic washers do get a mention .... there is hope then via Alphasonics perhaps

The above HTM 01 -05 has not been updated since 2013 ... but HTM 01-01 was in 2016 to add prion/protein residual testing levels after cleaning.

Thus HTM 01-05 is useless in its current format

See how an industry champion has utilized it ... and note Prion does not get a mention ... very very BAD

HTM 01-05: eating the elephant a bite at a time
Emma Male
BDJ Team volume 3, Article number: 16084 (2016)





So a few more sales possibilities then than Hospitals it would appear... perhaps SDI could offer them a special rate as the volume looks very large.

Another Distributor needed perhaps with contacts to the Dental Industry ?



The need for ProReveal is explained in the link below


When is YOUR next dental appointment ?

Protect Your Patients and Practice from Prions, Viruses, and Systemic Disease

06 Mar 2018




Out of those 35,000 Dental Practices I would say a minimum of 1,000 would be big enough to afford to buy ProReveal and set its costs against their big Tax Bill

Which represents 5 TIMES the size of the NHS Hospital market

[rivaldo] 18/1/2019 08:29

As well as the new acquisition, JDG also issued an excellent trading update yesterday, which noted:

"momentum in demand accelerated in the second half"
"healthy commercial activity and...excellent exchange rates"

So things are looking good for SDI at present. There's evidently still a seller or two out there supplying stock. Given SDI's usual illiquidity this would seem to be a good time for new buyers to build a decent holding. Hopefully it won't take much more buying to get rid of any overhang.

[buywell3] 17/1/2019 19:26

So what we have is a new business to also add to and improve other offerings within the Group as per usual.








Ionscope manufactures Scanning Ion Conductance Microscopes, using patented technology originally developed by a team of scientists from Imperial College London and The University of Cambridge. Our Scanning Ion Conductance Microscope (SICM) products enable workers in physical, material and life sciences around the world to perform minimally invasive topography scanning of soft, delicate, targets. We are currently export our microscopes to leading researchers Europe, North America, and Asia for use in cutting edge cellular, physiologically, and therapeutic research.

Ionscope is now a brand of openiolabs Ltd. Ionscope is the world-leader in Scanning Ion Conductance Microscopy (SICM), a rapidly emerging Scanning Probe Microscopy (SPM) technique which allows nanoscale topographical mapping of soft and delicate surfaces.

The Ionscope Scanning Ion Conductance Microscope (SICM) is a state-of-the-art nanometre imaging system.

It comprises a scan head, a controller, and data-acquisition systems. The robust mechanical design of the Ionscope SICM ensures high precision measurements.

It can be used as a standalone system or integrated with an inverted light (or confocal) microscope.

The ionscope image software offers a variety of supported modes and in-built system functions such as automated immersion, surface detection, real-time ion current display, real-time 2D and 3D display of images as they are formed.

[buywell3] 17/1/2019 18:11

Scientific Digital Imaging Plc Acquisition
17/01/2019

Scientific Digital Imaging plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, including life sciences, healthcare, astronomy, manufacturing and art conservation, announces concurrent with the announcement made today by DeepMatter plc (AIM:DMTR) ("DeepMatter"), that on 15 January 2019 the Group's subsidiary, Synoptics Limited, acquired the Scanning Ion Conductance Microscope ("SICM") business of DeepMatter (the "Acquisition").

The Acquisition, by way of an asset purchase agreement, complements the existing product offering of Synoptics. The SICM business under the Ionscope brand will be managed alongside the existing Synoptics brands of Syngene, Synbiosis and Synoptics Health. The Acquisition is not a substantial transaction for SDI under the AIM Rules for Companies.








buywell adds

SICM was used to image a living neural cell from rat brain, determine the life cycle of microvilli, and observe the movement of protein complexes in spermatozoa.

SICM has been combined with fluorescence microscopy

SICM can be combined in one instrument with optical and fluorescent methods and allows drawing structure-function correlations.




Scanning ion-conductance microscopy (SICM) is a scanning probe microscopy technique that uses an nanopipette as the probe tip.

SICM allows for the determination of the surface topography of micrometer and even nanometer-range structures in aqueous media conducting electrolytes. The samples can be hard or soft, are generally non-conducting, and the non-destructive nature of the measurement allows for the observation of living tissues and cells, and biological samples in general.

It is able to detect steep profile changes in samples and can be used to map a living cell's stiffness in tandem with its detailed topography, or to determine the mobility of cells during their migrations.

At the same time pipette movement is recorded and this generates a three-dimensional topographical image of the sample surface. SICM represents an alternative to conventional high-resolution microscopy, especially in imaging topography of live biological samples. In addition, the nanopipette probe provides a host of added modalities, for example using the same pipette and feedback control for efficient approach and seal with the cell membrane for ion channel recording.

SICM can be combined in one instrument with optical and fluorescent methods and allows drawing structure-function correlations.

It can also be used for precise mechanical force measurements as well as vehicle to apply pressure with precision. This can be done on living cells and tissues for prolonged periods of time without them loosing viability. The SICM is a multifunctional instrument, and it is maturing rapidly and will open even more possibilities in the near future.

In short ... a very useful tool that can measure to about 3 one thousands of a millionth of a metre.

or 3 X 10 to the power -9 metres ( hence we are talking cellular levels)

Understanding cellular structure is key to understanding cellular regulation. New developments in super-resolution fluorescence imaging, electron microscopy, and quantitative image analysis methods are now providing some of the first three-dimensional dynamic maps of biomolecules at the nanometer scale. These new maps—comprehensive nanometer-scale cellular cartographies—will reveal how the molecular organization of cells influences their diverse and changeable activities.

[rivaldo] 16/1/2019 15:26

Interesting piece about laboratory ovens, with a nice mention for SDI:



Extracts:

"Laboratory Ovens Exhibit High Utility in Forensics as Manufactures Focus on Product Innovations
January 15, 2019"

"Vacuum ovens are expected to hold a quarter share in laboratory ovens market through 2019 with surging demand from forensic, clinical and research laboratories, in order to cater to the growing needs of delicate drying processes such as removing flammable solvents and drying tiny parts.

Manufacturers such as Scientific Digital Imaging plc are taking up immense efforts in expanding their global distribution networks by making strategic acquisitions and are introducing new territories that would help them in reducing manufacturing costs and increase sales. In addition, emergence of vacuum ovens that deliver maximum efficiency in purging solvents such as the butane hash oil, is expected to further dive-in opportunities for expansion of customer-base in laboratory ovens market."

[xajorkith] 16/1/2019 13:51

May not be the bottom depending on the general market mood, but couldn't resist adding more recently.

Too much quality here to stay down for long.

[buywell3] 15/1/2019 22:43

.............. Alzheimer's and ProReveal ..................


I have been doing a lot of research on the prevalence of Alzheimer's and how the numbers of people getting it keep on rising and rising. ( read my last post)

Plus it is widely thought that the majority of cases never get properly diagnosed or even reported as many families look after their own elderly.

Something called Amyloid Beta protein has been linked with Alzheimer's in that it appears in the brains of many Alzheimer's sufferers.

There is a great medical debate now going off and has been for several years now that Amyloid Beta protein is a form of prion protein.

Which if the medical profession concede to or agree with ... means that Alzheimer's becomes a transmissible disease ie you can acquire it from a dirty surgical instrument.

IMHO from what I have read thus far in the last 2 years on the subject I truly believe that Alzheimer's is indeed a form of prion disease and thus you can catch it.

More Neurosurgeons get Alzheimer's than the norm

More Alzheimer's carers get Alzheimer's themselves than the norm

Interestingly the country with the highest %age of Alzheimer's sufferers is Finland
( Where CWD has been detected recently as in the USA with Deer/Moose and Elk)

Guess what ... the USA comes in at number 2 on the list with 50% of USA states affected by CWD.

May 2018,

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery


'' Amyloid-β (Aβ) is a peptide deposited in the brain parenchyma in Alzheimer’s disease and in cerebral blood vessels, causing cerebral amyloid angiopathy (CAA). Aβ pathology is transmissible experimentally in animals and through medical procedures in humans, such as contaminated growth hormone or dura mater transplantation in the context of iatrogenic prion disease.

Here, we present four patients who underwent neurosurgical procedures during childhood or teenage years and presented with intracerebral haemorrhage approximately three decades later, caused by severe CAA.

None of these patients carried pathogenic mutations associated with early Aβ pathology development. In addition, we identified in the literature four patients with a history of neurosurgical intervention and subsequent development of CAA.

These findings raise the possibility that Aβ pathology may be transmissible, as prion disease is, through neurosurgical procedures.''

''The possibility of transmission of Aβ proteopathic seeds should be taken into account when assessing the safety of surgical procedures, including the adequate sterilisation of reusable surgical instruments [14, 46] and use of disposable instruments where appropriate.''





Recent medical articles in the last 12 months have shown prions were present on the skin and eyes of people that had died from various forms of CJD ( a prion disease)


IMO such prions are also present on the skin and eyes of people that die of Alzheimer's


How many people suffering with earlier stage Alzheimer's have various operations that are none neurosurgical eg appendix removal or a hernia operation

At present

Health Technical Memorandum 01-01:

Management and decontamination of surgical instruments (medical devices)used in acute care

Does not specify that surgical instruments should be tested after being used on Alzheimer's sufferers



I think it should and soon will

Why has the guidance been updated?

HTM 01-01 has been updated to take account of recent changes to the ACDP-TSE
Subgroup’s general principles of decontamination (Annex C).

In relation to the decontamination of surgical instruments, this principally relates to paragraphs C21 and C22:

Protein detection

C21. Work commissioned by the Department of Health indicates the upper limit of acceptable protein
contamination after processing is 5µg BSA equivalent per instrument side.

A lower level is necessary for neurosurgical instruments.

C22. It is necessary to use protein detection methods to check for the efficient removal of protein from surgical instruments after processing.

Protein levels are used as an indication of the amount of prion protein contamination.

Ninhydrin swab kits are commonly used for this purpose,but recent evidence shows that ninhydrin is insensitive.

Furthermore, proteins are poorly desorbed from instruments by swabbing. Other commonly used methods have also been shown to be insensitive.



The above however only is being applied to Eye surgery ( near the brain ) and Neurosurgery ... what a crass mistake methinks

[buywell3] 14/1/2019 07:22

...............USA and contaminated surgical instruments ..................


I have just looked at what things are specified re CJD ( a prion disease) and the cleaning of surgical instruments in America.

The guidance is very out of date and testing and measurement of protein residue on the face of surgical instruments after cleaning/washing/sterilization does not seem to even get a mention.






Hence I forecast that in the USA the first animal form of TSE to cross the barrier to humans ( might be CWD ) will go through the USA like wildfire.

If Alzheimer's is proved to be a prion disease ( see my AZN thread ) ... then it already is.

The USA has one of the highest rates of Alzheimer's in the world

Proportion of People With Alzheimer’s Disease in the United States by Age:

85+ years, 38%, 75-84 years, 44%, 65-74 years, 15%, , and it is lethal ... no cure ... just like a prion disease.

[buywell3] 13/1/2019 23:01

............. ProReveal : The story so far ...............

I have made no secret that it was ProReveal which first attracted me to SDI.

The need for such an instrument was and now is even more evident as the incidence of prion disease gets worse as the understanding of what it is and how many types of it exist.

The Department of Health (DOH) realize this and acted albeit very weakly IMO when it issued this in 2013


But typically of the wimps that we get as Ministers of Health the title was

Guidance

Decontamination of surgical instruments (HTM 01-01)

See it was that one word that showed how spineless Jeremy Hunt was .. (and still is regarding Brexit).

The word was .... GUIDANCE


This guidance was update in 2016

8 July 2016

Updated the documents based on the Advisory Committee on Dangerous Pathogens' Transmissible Spongiform Encephalopathy (ACDP-TSE) subgroup guidance, the views of the Society of British Neurological Surgeons and to align with UK devolved administrations. (Previously decontamination of surgical instruments (CFPP 01-01))


So it was updated regarding '' Transmissible Spongiform Encephalopathy '' and dangerous pathogens


Just so we understand what the DOH does not want to say to the public

This means ..... TRANSMISSIBLE PRION DISEASES



Transmissible spongiform encephalopathies (TSEs) are a group of progressive, invariably fatal, conditions that are associated with prions and affect the brain (encephalopathies) and nervous system of many animals, including humans, cattle, and sheep.


buywell Note : you can add loads of other animals to that list above now , including deer which have TSE in over 50% of all USA states and just over a year ago Camels.

Governments around the world are keeping a lid on just how bad the situation is with prion diseases. Because there is no cure , prions are not alive and thus can't be killed . All humans have prion protein naturally within their body.

It is mutations of it that kill us

PRNP prion protein [ Homo sapiens (human) ]
Gene ID: 5621, updated on 6-Jan-2019




Re ProReveal and the current uptake of it within the NHS & DOH guidance HTM 01-01


I am going to put up a post on here soon where I will urge the SDI BOD to either but preferably all:

put a one page ad in a daily newspaper

put a youtube video of an interview with either the Chairman or CEO

Contact their local MP to make him aware of the ProReveal situation within the NHS

get a radio and TV interview to explain the situation



This is why



In the USA Hospitals are FAILING federal inspections involving dirty surgical instruments and no SSI (surgical site infection) surveillance documented for surgeries where contaminated instruments were entered on Adverse Event Reports




This type of problem is costing the USA $ Billions a year

SURGICAL SITE INFECTIONS CONTINUE TO HAUNT THE HEALTHCARE INDUSTRY
Sep 14, 2016


“The estimated cost of SSI’s to hospitals is $7.4 billion, with 13,088 deaths per year”.

A 'compliance check' at this UC San Diego hospital finds surgical instruments with 'red stains on '

California Dept of public Health declared ''Immediate Jeopardy'' this has happened 7 times before at the same Hospital , a fine imposed of $44,000.

Proper cleaning required before sterilization





Seems a fairly common USA problem

Dirty, missing instruments plague DMC surgeries



Then the same problem at the same Hospitals occurs again
Inspections begin at DMC hospital after dirty instruments allegation


The USA has a problem
Clinical Leadership & Infection Control
Bone, blood, bugs found on instruments at Denver hospital after surgical breach, report says
June 14, 2018



In the USA things seem worse than the UK but are they ? we don't know is the answer

The legal bills for dirty contaminated surgical instruments grows however

A widespread problem

Many people may think that such events are rare, but The Center for Public Integrity points out that hospitals across the country are discovering that their surgical tools are far from clean. In some cases, staff had failed to follow manufacturer cleaning instructions but in others, contamination including bone, rust, skin tissue, blood and bacteria were discovered on the instruments after they were properly cleaned and then examined with a small video camera.

Part of the problem seems to come from the advancement of medical instrument technology which now creates complex tools with movable parts that are small, and that are made out of plastics, polymers and tungsten. These materials are much harder to clean than stainless steel and glass, and therefore, sterilization is not enough to remove contaminants. Another factor may be the high volume of surgical tools which are sterilized each day and the environment in which they are cleaned.

Until hospitals and manufacturers figure out a solution that fixes these issues, patients in Santa Fe Springs and elsewhere will continue to find themselves exposed to harmful superbugs and other contaminants. Patients who are victims of these medical issues may find it helpful to speak with a personal injury attorney.


But at least checks get done in America ... and Hospitals are getting named

............................... What about the NHS ......................................


What UK Government Inspections are carried out on NHS Hospitals to see that procedures and testing checks are done to collate data and avoid dirty surgical instruments and SSI's (surgical site infections) and that Hospitals document and keep records up to date ?

What UK Government agencies are doing the above ?


I don't think anything is being done whatsoever and that the majority of NHS Hospitals are still carrying on like they did 20 years ago

Thus HAI's are costing over the NHS and hence the UK taxpayer , over 1 Billion a year ... but worse still people are catching nasty transmissible diseases many of which take years before they become apparent and many that kill or reduce the quality of life of the recipient of such a disease.


In short a list of NHS Hospitals that comply with HTM 01-01 needs to be produced and made public

In other words a list of NHS Hospitals that have adopted ProReveal to use in their SSD's

[buywell3] 13/1/2019 21:38

I think it fair to say that many Institutions read and act based upon guidance given by Brokers as do other investors ... my other point is that anybody can give forward share price price guidance using a number that the share price has already reached .

That such type or method of 'behind the curve' guidance is being employed in what is obviously a growth stock giving decent updates and hitting record results one after another is plain and simply ...

Just not good enough

[solooiler] 13/1/2019 20:44

That would imply that the institutional investors are effectively idiots which they may be but I doubt it. SCSW positive small mention this weekend

[buywell3] 13/1/2019 20:39

There is a case for an argument that the reason for the two major investors recently selling SDI is because FinnCap stuck with a forward guidance price which has already been exceeded.

IMO such guidance is not forward looking ... rather the opposite in fact.

As they have been for the last 2 years if you look back ... they give forward guidance IMO looking in the rear view mirror ... do they get paid for this ?

The upshot is SDI is now a sitting duck for a foreign predator that would probably buy it for 44p a share

[petewy] 13/1/2019 13:14

Thanks Hastings. Who's Charlie?

[discodave4] 13/1/2019 12:36

Thanks Charley.

[hastings] 13/1/2019 10:11

Hi Pugugly, thanks for posting, appreciated. The piece I was actually referring to didn't for some reason get uploaded to the site, rather it remained in print.

Anyway I have dug it out and whilst nothing new it may be of use to some of the SDI newcomers. Good to see an ever increasing bunch of well informed and savvy investors here.


----Scientific Digital Imaging now HQ based on the edge of the city at
Waterbeach has once more demonstrated that it is continuing on its
more recent growth path, having delivered another set of excellent
Interim results.

SDI now boasts a number of complementary arms within its group,
spanning life sciences, healthcare, astronomy and leisure markets
that have an increasingly global feel.
Ably navigated by Chairman Ken Ford and CEO Mike Creedon the
company announced a substantial 23% increase in revenue to
£8.04m, whilst adjusted pre-tax profits also jumped by a marked
32% to £1.46m.
Importantly, cash generation was particularly strong with a 103%
improvement to £1.53m as Ford added that it had been a record-
breaking six month period for the company.

Catching up with the Chairman this morning it is clear that the board
is very pleased with the progress made thus far, whilst reiterating its
commitment to further bolt on acquisitions.
“We have a number of opportunities in the pipeline with four or five
that we are currently looking at” says Ford, where he goes on to
add that they are confident of tying at least one of these up by the
end of the current financial year.
In terms of the overall group Ford adds “we are currently firing on all
cylinders with the businesses generating cash, so at present, we
are happy with where we are at”.
ATIK, Sentek and the Astels arms are singled out as very positive
performers, whilst Ford also points out that the Synoptics operation
has been turned around from a loss making business to profit, with
new and more simplified products now feeding through.

The ground breaking and highly acclaimed Pro-Reveal device is
also making tentative progress against a backdrop of a cash
strapped NHS, Ford pointing out that the NHS is actually at present
going against its own DOH advice around the cleansing of hospital
instruments.
Looking ahead, Ford reiterates that the business is in a good place
and the strategy is to continue on its growth path where it has both
cash and bank facilities in place to support its business plan.

Any future placing to raise additional funds would only be considered
should a much larger opportunity emerge, although that doesn't
appear to be on the agenda at present, the company seemingly
happy to bolt-on smaller niche/complementary purchases.

Although the house broker FinnCap is currently sticking with its 44p
target price and adjusted pre-tax profits of £2.6m for the current
year, given that SDI is running comfortably in-line with forecasts
then there is arguably potential for a future upgrade to numbers.

Ignoring any forthcoming addition to the wider group which would
boost numbers, next years forecasts see revenue increasing to
£16.8m providing for adjusted pre-tax profits of £2.9m and EPS of
2.7p.
The free cash flow yield is expected to come in at 7% where net
cash on the balance sheet should increase to £3.9m.
Although Brexit issues have contributed to a drag on the domestic
stock market and in keeping with others SDI shares have come off
from its yearly high, the company looks better placed than many in
this area and has prepared for any potential disruptions.

[rivaldo] 13/1/2019 08:14

Agreed hastings. I bought some more on the dips at the end of last week and am similarly relaxed and optimistic that the last three years or so's progress will be maintained.

[pugugly] 12/1/2019 18:20

hastings - Done it for you - Good seach engine in your local paper!!

Is this the one you refer to?

[hastings] 12/1/2019 17:13

Some great posts which is good to see and I particularly concur with Rhomboid. I'd just also add that regarding the institutional sales it's worth noting that where there has been significant profit, something has been taken off the table regarding a number of stocks, particularly in wake of the market turning.Very relaxed personally and extremely pleased with how things have progressed over the last three years. I'll try and dig out my piece I penned for the Cambridge News following the interims when I spoke with Ken Ford.Nothing new in that, but may be of interest now we have some more recent investors on board.

[spann_703] 12/1/2019 09:19

Pireric, I think you hit the nail firmly on the head - this is one of all too few quality small caps as judged by any reasonable set of metrics such as cashflow, growth and valuation. I am a new holder here, but intend to add should the price remain at about these levels or below.

[rhomboid] 12/1/2019 06:00

Eric I would add that FX aside SDI Director view re Brexit was it would have little impact other than potentially to improve the pipeline of potential acquisitions as nervous vendors make for better deals.

I’d also say it’s eminently possible for private investors to take up the slack from Octopus divestment..this is a tiny company with only a £30m market cap and Octopus held only 6.8m shares as at Jan 4 RNS so only c£2.3m worth to exit completely

Finally I’ve a sense that we can’t be too far off the next acquisition news which will provide a further insight into what looks a compelling growth story here

I hold a few...well quite a lot actually

[pireric] 11/1/2019 21:47

Not many medium-high quality stocks at all in the small cap space yielding anywhere close to 5% free cash flow on a normalised basis, let alone 6.5 - 7% with SDI. Which I think is an absolutely major difference versus most shares trading on a calendar year 2019 P/E of sub 18x. And SDI is only on 13.1x. And forecasts look unduly pessimistic unless we get a no deal Brexit.

A lot of other stocks I have looked at look good value at first glance, but then turn out to only be mediocre value when you look at their cash flow. SDI both looks good value at first glance, and then appears great value at second glance.